Globus Medical Inc
Change company Symbol lookup
Select an option...
GMED Globus Medical Inc
DX Dynex Capital Inc
BMO Bank of Montreal
FPRX Five Prime Therapeutics Inc
VTR Ventas Inc
PENN Penn National Gaming Inc
SUN Sunoco LP
SWKS Skyworks Solutions Inc
VOO Vanguard S&P 500 ETF

Health Care : Health Care Equipment & Supplies | Mid Cap Growth
Company profile

Globus Medical, Inc. is a medical device company. The Company is focused on developing products for patients with musculoskeletal disorders. It is focused on products to treat patients with spine disorders. The Company's products fall under categories, which include Innovative Fusion and Disruptive Technologies. The Innovative Fusion category products include fusion products to treat spinal disorders for the entire spine, and they can be used in various surgical approaches. The Disruptive Technologies category represents a shift in the treatment of spinal disorders by allowing for surgical procedures and the treatment of spinal disorders. QUARTEX is its Occipito-Cervico-Thoracic (OCT) stabilization system. QUARTEX features a threading locking cap to enable low-torque. The Company's portfolio of approved and pipeline Disruptive Technology products includes products that allow for minimally invasive surgical (MIS) techniques.

Closing Price
Day's Change
-1.06 (-1.93%)
B/A Size
Day's High
Day's Low

10-day average volume:

UPDATE: Adobe shares rise 3% on revenue, earnings beat

6:12 pm ET September 15, 2020 (MarketWatch)

Adobe Inc. (ADBE) shares were up 3% in after-hours trading Tuesday after the software company reported ( fiscal third-quarter results that bested Wall Street estimates. Adobe reported net income of $955 million, or adjusted earnings of $2.57 per share, compared with net income of $793 million, or $1.63 a share, in the year-ago quarter. Revenue rose 14% to a record $3.23 billion from $2.8 billion a year ago. Fourth-quarter guidance was also above estimates. "Normally, Q3 is a seasonally slow quarter for us, but small businesses and education fully embraced digital tools during the pandemic," Adobe Chief Financial Officer John Murphy told MarketWatch in a phone interview after the results were announced. "This is a long-running trend." Analysts surveyed by FactSet had expected adjusted earnings of $2.41 a share on revenue of $3.16 billion. Adobe shares are up 51% this year as it continues to feel the effects of the pandemic. The broader S&P 500 index has improved 5.3% in 2020.

-Jon Swartz; 415-439-6400;

(END) Dow Jones Newswires

September 15, 2020 18:12 ET (22:12 GMT)

Copyright (c) 2020 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.